Cellulose-based biocomposites, such as Cottonid, are a promising class of materials to improve the carbon footprint of products during their service life. Cottonid has high technological potential due to its physical and mechanical similarities to engineering plastics and light metals. To replace traditional metallic materials in industry, cellulose-based semi-finished products need to be formed and cut. In particular, blanking is the most cost-effective and industrially common cutting method for metals. However, this study investigates the influence of various blanking process parameters on the quality and the fatigue strength of the resulting cutting edges of Cottonid. The presented results give insights on how the relationships between process parameters during cutting and resulting material properties known from conventional materials can be transferred to cellulose-based biocomposites like Cottonid. The relative clearance was varied between 4 and 10% and the cutting velocity between 0.05 and 10 m/s. It was evident that slower velocities and smaller clearances resulted in visibly better cutting edges. In order to relate this effect to the mechanical performance of Cottonid, new 3-point bend specimens were taken from the blanked strips for fatigue testing. It was found that the fatigue strength was significantly affected by the velocity and clearance. Further, similar to metallic materials, clean-cut (smooth area) and a fractured zone can be clearly distinguished. A good cutting edge quality results in a higher resistance of the Cottonid component against crack initiation at process-induced defects. The knowledge gained may enable an efficient cutting process for cellulose-based materials with higher fatigue strength in the future.
Industrial manufacturing is undergoing a biological transformation, which has become a growing part of current research in production engineering. The technologies involved help to translate innovative approaches into existing or novel medical devices. Currently, however, even the most advanced blood contacting medical devices fail to be sufficiently inert to blood, thus causing acute effects – coagulation, inflammation, embolism, stroke – as well as chronic ones – inflammation and chronic use of anticoagulants. We present the marriage of advanced molecular science, nanotechnology and advanced production engineering to improve the hemocompatibility of hemodynamic systems, such as artificial hearts. Our consortium has joined forces to develop nature-inspired coating systems that improve hemocompatibility, prohibit adhesion of bacteria and minimize the growth of dangerous large thrombi. We achieve this by (1) concealing the presence of the titanium surface, thereby minimizing the activation of inflammatory and coagulatory reactions, (2) locally inactivating those molecules that cause uncontrolled coagulation, (3) directing the blood to use its own fibrinolytic system to digest the clot and (4) introducing micro surface patterns that interfere with the flow near the surface generating shear, which in turn prohibits dangerous clots from growing. In vitro tests demonstrate considerable improvement in hemocompatibility.